Cargando…
A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine
A mouse model of SARS-CoV-2 that can be developed in any molecular biology lab with standard facilities will be valuable in evaluating drugs and vaccines. Here we present a simplified SARS-CoV-2 mouse model exploiting the rapid adenoviral purification method. Mice that are sensitive to SARS-CoV-2 in...
Autores principales: | Jawalagatti, Vijayakumar, Kirthika, Perumalraja, Hewawaduge, Chamith, Park, Ji-Young, Yang, Myeon-Sik, Oh, Byungkwan, So, Mi Young, Kim, Bumseok, Lee, John Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888445/ https://www.ncbi.nlm.nih.gov/pubmed/35250985 http://dx.doi.org/10.3389/fimmu.2022.811802 |
Ejemplares similares
-
Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2021) -
Oral mRNA Vaccines Against Infectious Diseases- A Bacterial Perspective [Invited]
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022) -
Evaluation of host and bacterial gene modulation during Lawsonia intracellularis infection in immunocompetent C57BL/6 mouse model
por: Kirthika, Perumalraja, et al.
Publicado: (2022) -
Targeting primary and metastatic tumor growth in an aggressive breast cancer by engineered tryptophan auxotrophic Salmonella Typhimurium
por: Jawalagatti, Vijayakumar, et al.
Publicado: (2022)